Search

everythinglearnresearchcommunity

for

Search:↓

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

The document concludes that skin and hair changes in small animals are often due to hormonal imbalances and recommends regular baths and antibiotics for associated infections.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Lower SHBG levels may increase the risk of PCOS.

SHBG may be a useful early indicator and treatment target for PCOS.